Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Principles of transparency and best practice
Management team
Open access
Subscription information
Contact us
BROWSE ARTICLES
All issues
Current issue
Ahead-of print articles
Most read articles
Most download articles
Most cited articles
Search
Author index
FOR AUTHORS AND REVIEWERS
Instructions for authors
Research and publication ethics
Author checklist
E-submission
Submission requirement form
Search
Search
Page Path
HOME
Search
Review Article
Current Understanding of Bladder Immune Response to BCG Therapy
Byung Hoon Chi , In Ho Chang
Korean J Urol Oncol.
2014;12(1):16-22. Published online April 30, 2014
PDF
Review Article
Emerging Diagnostic Tools for Bladder Cancer
Seung Il Jung
Korean J Urol Oncol.
2013;11(1):17-24. Published online April 30, 2013
PDF
Review Article
Translation Researches Using Genome-wide Association Studies(GWAS) in Bladder Cancer
Seok Joong Yun , Wun-Jae Kim
Korean J Urol Oncol.
2012;10(3):113-118. Published online December 30, 2012
PDF
Review Article
Role of Fluorescence Cystoscopy: Diagnostic Method to Increase the Detection Rate of Bladder Cancer
Ill Young Seo
Korean J Urol Oncol.
2010;8(1):18-22. Published online April 1, 2010
PDF
Review Article
Post-operative Surgical Margin Positive Cases in Bladder Cancer: Radical or Partial Cystectomy
Do Hwan Seong
Korean J Urol Oncol.
2009;7(3):122-124. Published online December 1, 2009
PDF
Review Article
Update of Intravesical Therapy on Non-Muscle Invasive Bladder Cancer
Hyun Yul Rhew , Taek Sang Kim
Korean J Urol Oncol.
2009;7(1):6-11. Published online April 1, 2009
PDF
Review Article
How do You Manage High Risk Bladder Cancer?
Jae-il Chung
Korean J Urol Oncol.
2008;6(3):111-116. Published online December 1, 2008
PDF
Original Article
Prognostic Value of Ki-67, Apoptotic Index and CD34 in Bladder Tumor: Correlation with Stage, Histologic Grade, Progression and Recurrence
Jae-Seung Chung , Ji-Young Han , Sang-Min Yoon , Do-Hwan Seong
Korean J Urol Oncol.
2008;6(1):24-30. Published online April 30, 2008
PDF
Original Article
The Bladder Tumor Antigen (BTA) Stat Test and NMP22 BladderChek Test Compared to Voided Urine Cytology in the Detection of Bladder Cancer
Du Yong Kim , Taek Sang Kim , Han Seok Kim , Byeong Ju Seong , Hyun Yul Rhew
Korean J Urol Oncol.
2007;5(2):97-101. Published online August 1, 2007
PDF
Review Article
Management of T1G3 Bladder Cancer
Youn Soo Jeon
Korean J Urol Oncol.
2007;5(2):74-79. Published online August 1, 2007
PDF
Case Report
Primary Cutaneous Metastasis of Invasive Bladder Cancer without Solid Organ Metastasis
Seung Hyun You , Seung Chol Park , Sang Hoon Baick , Joung Sik Rim
Korean J Urol Oncol.
2006;4(1):31-33. Published online June 30, 2006
PDF
Original Article
Expression of the Insulin-like Growth Factors(IGFs) and Insulin-like Growth Factor Binding Proteins(IGFBPs) in Bladder Cancer Tissue
Min Woo Lee , Myoung Jae Kang , Pyoung Han Hwang , Young Beom Jeong , Hyung Jin Kim
Korean J Urol Oncol.
2004;2(2):66-71. Published online June 30, 2004
PDF
Original Article
The Predictors of Recurrence and Surveillance in Superficial Bladder Cancer
Soo Eung Chai , Jeong Hee Hong , Hyun Moo Lee , Han Yong Choi
Korean J Urol Oncol.
2004;2(1):41-46. Published online March 30, 2004
PDF
Original Article
The Efficacy of NMP22 BladderCheck
TM
on Screening for Bladder Cancer
Young Hwii Ko , Jae Hyun Bae , Hong Seok Park , Duck Ki Yoon , Jun Cheon
Korean J Urol Oncol.
2003;1(2):193-198. Published online June 30, 2003
PDF
Original Article
Comparison of the NMP-22 Test, BTA TRAK Assay and Cytology in the Detection of Bladder Cancer
Kang Hyun Lee
Korean J Urol Oncol.
2003;1(1):95-99. Published online March 30, 2003
PDF
1
2
3
4
Journal of
Urologic Oncology
Print ISSN: 2951-603X
Online ISSN: 2982-7043
MOST READ
MOST CITED
11,671
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
11,613
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
9,216
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
8,093
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
7,700
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
+more
Cited By
11
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By
8
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By
7
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By
5
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
Cited By
5
Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
+more